Guangdong Hybribio Biotech Co., Ltd.
Biotechnology and laboratory services · Chaozhou, Guangdong
About Guangdong Hybribio Biotech Co., Ltd.
Guangdong Hybribio Biotech Co., Ltd. is a Chinese biotechnology company founded in 2003 and headquartered in Chaozhou, Guangdong Province, specialising in in-vitro molecular diagnostics. Listed on Shenzhen's ChiNext board (300639), it covers the full chain of the sector, from research and development to the manufacture and sale of nucleic acid diagnostic reagents and instruments for hospitals and medical institutions.
Its best-known line is human papillomavirus (HPV) testing, with high-risk genotyping kits based on nucleic acid hybridisation technology, joined by assays for sexually transmitted diseases, thalassaemia, prenatal and postnatal screening and other molecular diagnostic panels. The company also develops the instruments and platforms that accompany its reagents.
For clinical laboratories and diagnostic distributors, Hybribio offers an integrated Chinese manufacturer with more than two decades in molecular diagnostics and Class III product registrations with China's medical products authority. This listing was corroborated against stock-market sources that consistently confirm its official website, hybribio.cn, its Chaozhou base and its activity; the site did not load in the text reader, so it is recorded as corroborated rather than verified.
Its best-known line is human papillomavirus (HPV) testing, with high-risk genotyping kits based on nucleic acid hybridisation technology, joined by assays for sexually transmitted diseases, thalassaemia, prenatal and postnatal screening and other molecular diagnostic panels. The company also develops the instruments and platforms that accompany its reagents.
For clinical laboratories and diagnostic distributors, Hybribio offers an integrated Chinese manufacturer with more than two decades in molecular diagnostics and Class III product registrations with China's medical products authority. This listing was corroborated against stock-market sources that consistently confirm its official website, hybribio.cn, its Chaozhou base and its activity; the site did not load in the text reader, so it is recorded as corroborated rather than verified.